Home | Reports | Startups | Press Releases | Blog | Online Store | site map


Developments

Financings

Reports

Startups
blog
Blog
Medtech podcast
Podcast

Cardiology

Surgery

Methodology

Order Report online

Micro- and Nanomedicine:  Technologies, Applications, Industry, and Markets Worldwide

 

Report #T625

· 280 pages   · 28 Exhibits   · 99 Company Profiles   · Pub. Date 06/2006   · Report #T625

This report details the current products and technologies under development and on the market with medical applications of nanotechnology and microelectromechanical systems (MEMS) The report details the current markets and their actual penetration by micromedical and nanomedical applications.  The technologies and applications under development are critically analyzed to identify the technological, market, regulatory and other hurdles that developers must be overcome for products to achieve commercialization. Opportunities are revealed for development of specific applications.  Nearly 100 companies are profiled for their current activities and competitive outlook, and many additional companies are referenced throughout the report.

Table of Contents

Report Sample

EXECUTIVE SUMMARY

 

 

Section 1:        Materials, Processes, Applications and markets

1.1       About Nanotechnology

1.1.1          Uses of Nanotechnology

1.1.2          Nano Building Bricks

1.1.2.1       C60/Fullerenes

1.1.2.2       Carbon Nanotubes

1.1.2.3       Nanoparticles

1.1.2.4       Nanowires

1.1.2.5       Molecular Nanotechnology

1.1.3          Nanotechnology Risks

1.1.4          Nanotechnology in the Marketplace

1.1.5          The Nanotech Industry

1.1.6          Financing Nanotechnology

1.2       MEMS

1.2.1          Common Applications for MEMS

1.2.2          Materials

1.2.2.1       Silicon

1.2.2.2       Polymers

1.2.2.3       Metals

1.2.3          Processes

1.2.3.1       Deposition

1.2.3.2       Lithography

1.2.3.3       Etching

1.2.4          Dry Etching

1.2.5          The MEMS Market

1.2.5.1       Current Market Sectors

1.2.5.2       The MEMS Industry

1.3       Summary

 

Section 2:        Biomedical Applications

2.1       Nanotechnology

2.1.1          Cancer Diagnostics and Therapy

2.1.1.1       Silica Nanospheres

2.1.1.2       Nanoscale Hydrogel Shells

2.1.1.3       Carbon Nanoparticles

2.1.1.4       Photodynamic Therapy and Gold

2.1.1.5       Dendrimer Conjugates

2.1.1.6       Ligand-targeted Emulsion Technologies

2.1.1.7       Linear Cyclodextrin-Containing Polymers

2.1.1.8       Smart Lipid-based Nanocarriers

2.1.1.9       Thermotherapy Using Magnetic Nanoparticles

2.1.1.10     Targeted Cell Destruction

2.1.1.11     Nanoshells

2.1.2          Drug Delivery

2.1.3          Diagnostic Tools

2.1.4          Various Therapeutic Targets and Technologies

2.1.4.1       Anthrax

2.1.4.2       Cholesterol

2.1.4.3       Artificial Retina

2.1.4.4       Nerve Regeneration

2.1.4.5       Crossing the Blood-Brain Barrier

2.1.4.6       Protecting Against Radiation Damage

2.1.4.7       Antibody Therapeutics

2.1.4.8       Silver Nanoparticles Against Infection

2.1.4.9       Haemostasis

2.1.4.10     Bone Fracture Repair

2.1.4.11     Dental Implant and Tissue Regeneration

2.1.4.12     Vaccine Adjuvant

2.1.4.13     Treatment of Thrombosis

2.1.4.14     Coatings for Stents and Other Devices

2.1.4.15     Detecting Nanobacteria

2.1.4.16     Killing Vviruses

2.2       MEMS

2.2.1          Sensors

2.2.1.1       Packaging Challenges

2.2.1.2       Sensor Manufacturers and Developers

2.2.2          Accelerometers

2.2.3          Lab-on-a-Chip and Related Microdevices

2.2.4          Insulin Pump

2.2.5          Infrastructure

 

Section 3:        Future Trends, Research and Risks

 

3.1       Prospectve Devices and Applications

3.1.1          Non-invasive Nanodevices

3.1.2          Extracellular Devices

3.1.3          Intracellular Devices

3.1.3.1       Nanomachines to Control Tissue Healing

3.1.3.2       Eliminating Viruses

3.1.3.3       Correcting Chemistry

3.1.3.4       New Organs and Limbs

3.2       Limitations and Realizable Markets

3.3       Fundamental Nanotechnology Research

3.3.1          U.S.A.

3.3.1.1       University at Albany-SUNY

3.3.1.2       Cornell University

3.3.1.3       University of Michigan

3.3.1.4       Rice University

3.3.1.5       University of Pennsylvania

3.3.1.6       University of Virginia

3.3.1.7       University of North Carolina

3.3.1.8       Ohio State University

3.3.1.9       Northwestern University

3.3.1.10     University of Pittsburgh

3.3.1.11     Case Western Reserve University

3.3.1.12     University of California at Berkeley

3.3.1.13     Arizona State University

3.3.1.14     University of New Mexico

3.3.2          Europe

3.3.3          Japan

3.3.3.1       Development of Active Targeting DDS

3.3.3.2       Development of Novel Tissue Engineering

3.3.3.3       Development of New Biomaterials

3.4       The Risk Factor

3.4.1          The Goo Scenarios

Section 4:        Markets for Nanotechnology and MEMS

 

4.1       Nanotechnology Markets

4.1.1          The Growth of Nanotechnology

4.1.1.1       Financing Nanotech

4.1.1.2       Company Involvement

4.1.1.2.1          Venture Capital

4.1.1.2.2          Intellectual property

4.1.1.2.3          NBA Poll

4.1.1.3       Medical Applications: Drug Delivery

4.1.1.4       Molecular Diagnostics

4.2       Regional Market Analysis

4.2.1          International Overview

4.2.2          USA

4.2.3          Europe

4.2.4          Japan

4.3       MEMS Markets

 

Section 5:        The Nanotech and MEMS industries

 

5.1       Nanotech Companies

5.1.1   Ablynx

5.1.2   Abraxis Bioscience

5.1.3   AcryMed Inc.

5.1.4   Acusphere Inc.

5.1.5   Advanced Magnetics Inc

5.1.6   Alltracell

5.1.7   AlphaRx

5.1.8   American Pharmaceutical Partners Inc.(American Bioscience Inc)

5.1.9   Anson Nano-Biotechnology Company Ltd

5.1.10   Angstrom Medica

5.1.11   Aphios Corp.

5.1.12   Applied Nanoworks

5.1.13   Avidimer Therapeutics (previously Nanocure)

5.1.14   Biocrystal Ltd

5.1.15   Biodelivery Sciences International (BDSI)

5.1.16   Bioforce Nanosciences Inc

5.1.17   Bio-Gate Bioinnovative Materials GmbH

5.1.18   BioLok International Inc.

5.1.19   Bionova Inc

5.1.20   Biophage Pharma Inc.

5.1.21   Biophan Technologies

5.1.22   Biosanté Pharmaceuticals Inc.

5.1.23   C Sixty Inc

5.1.24   Capsulution Nanoscience AG

5.1.25   Combimatrix Corporation

5.1.26   Damage Prevention Concept

5.1.27   Farfield Sensors Ltd

5.1.28   Flamel Technologies SA

5.1.29   GE Healthcare Sciences (Amersham Biosciences Corp)

5.1.30   HealthPlus International Inc.

5.1.31   IGI Inc.

5.1.32   ImaRx Therapeutics Inc

5.1.33   Immunicon Corporation

5.1.34   Insert Therapeutics Inc.

5.1.35   Introgen Therapeutics

5.1.36   JR Nanotech plc

5.1.37   Kereos Inc.

5.1.38   Keystone Nano

5.1.39   Kliendieck Nanotechnik

5.1.40   Labopharm Inc.

5.1.41   LiPlasome Pharma A/S

5.1.42   Lumera Corporation

5.1.43   Magforce Nanotechnologies AG

5.1.44   MagnaMedics GmbH

5.1.45   MFIC Corporation

5.1.46   MIV Therapeutics Inc

5.1.47   Molecular Profiles

5.1.48   Nanobac Pharmaceuticals Inc

5.1.49   NanoBio Corporation

5.1.50   Nanobiotix

5.1.51   Nanocarrier Co Ltd

5.1.52   Nanocopoeia Inc.

5.1.53   Nanocrystal Technology

5.1.54   Nanocyte Inc.

5.1.55   Nanogen Inc

5.1.56   NanoInk, Inc.

5.1.57   Nanologix Inc.

5.1.58   NanoMed Pharmaceuticals Inc

5.1.59   Nanomix Inc

5.1.60   NanoPharm AG

5.1.61   Nanospectra Biosciences Inc.

5.1.62   Nanosphere, Inc.

5.1.63   Nanostream Inc.

5.1.64   Nanostructures, Inc.

5.1.65   Nanosyn Inc.

5.1.66   Nanotherapeutics Inc

5.1.67   Nanotrope Inc

5.1.68   Nanoviricides

5.1.69   Nexxion Corporation

5.1.70   Nucryst Pharmaceuticals

5.1.71   Nutralease

5.1.72   Orion Integrated Biosciences Inc.

5.1.73   Orthovita Inc.

5.1.74   pSivida Ltd

5.1.75   Qiagen N.V.

5.1.76   Solubest Ltd

5.1.77   Sphere Medical Ltd.

5.1.78   Spherics Inc.

5.1.79   Spinelix

5.1.80   Starpharma Pooled Development Ltd

5.1.81   SurgRx Inc.

5.1.82   Tecan Group Ltd

5.1.83   Telemolecular Corporation

5.1.84   TransGenex Nanobiotech, Inc.

5.1.85   Veredus Laboratories Pte Ltd

5.2       MEMS Companies

5.2.1   Apogee Technology Inc.

5.2.2   Aquamarijn MicroFiltration BV

5.2.3   Caliper Life Sciences

5.2.4   CardioMEMS Inc

5.2.5   Cascade Microtech, Inc.

5.2.6   Colibrys (Switzerland) Ltd

5.2.7   IMT

5.2.8   MEMSCap SA

5.2.9   MEMX

5.2.10   Micralyne Inc

5.2.11   Micronics Inc

5.2.12   Silex Microsystems AB

5.2.13   TRONIC Microsystems S.A.

 

Appendix I:    Company Directory

 

Appendix II:   Glossary

 


 

Micro- and Nanomedicine:  Technologies, Applications, Industry, and Markets Worldwide

 

Report #T625

May 2006

 

Price:

Print or PDF: $1,650

Print and PDF: $1,850

 

Add $1,500 for site license or $2,500 for global license   [what's this?]

Order online.

 

Methodology.
MedMarket Diligence Reports are produced through primary and secondary research. Data is gathered from published sources on products and technologies on the market and under development.  Clinicians and industry representatives are interviewed for their knowledge and insights on product development, market development, clinical practice and trends associated with the evolving use of technologies. Secondary data is used to corroborate and support assessments and projections.  Reports are written and researched by industry insiders, whose familiarity with the companies, industry dynamics and other marketplace specifics facilitate the research process and ensure high quality and thorough reports.

 

 Contact: Patrick Driscoll, (949) 859-3401.

Copyright © 2006 MedMarket Diligence, LLC. All rights reserved.
Revised: 02/16/11

Or call
+1.949.891.1753

+1.949.859.3401
+1.949.837.4558 fax
1.866.820.1357 toll-free (US)

 

 
Follow us on Twitter
Follow medmarket

MedMarket Diligence Reports

 

White Paper
High Growth
Medical Technologies

October 2009

 

 

Medtech Startups
Online database of recent medtech startups

 

 

Contact Us